4.6 Article

Islet Survival and Function Following Intramuscular Autotransplantation in the Minipig

Journal

AMERICAN JOURNAL OF TRANSPLANTATION
Volume 13, Issue 4, Pages 891-898

Publisher

WILEY-BLACKWELL
DOI: 10.1111/ajt.12136

Keywords

Porcine islets; preclinical studies; revascularization; suppress engraftment

Funding

  1. 7th Framework Programme of the European Commission (Beta-Cell Therapy) [ANR-10-LABX-46]
  2. INSERM (Programme National de Recherche sur le Diabete)
  3. Conseil Regional Nord-Pas de Calais
  4. University of Lille2
  5. Fonds Europeen de Developpement Economique et Regional
  6. Agence de Biomedecine
  7. Oncosuisse [OCS-01778-08-2005]
  8. European Genomic Institute for Diabetes (EGID) [ANR-10-LABX-46]

Ask authors/readers for more resources

The liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response (IBMIR), and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation (IMIT) offers an attractive alternative, based on its simplicity, enabling easier access for noninvasive graft imaging and cell explantation. In this study, we explored the outcome of autologous IMIT in the minipig (n = 30). Using the intramuscular injection technique, we demonstrated by direct histological evidence the rapid revascularization of islets autotransplanted into the gracilius muscle. Islet survival assessment was performed using immunohistochemistry staining for insulin and glucagon up to a period of 6 months. Furthermore, we showed the crucial role of minimizing mechanical trauma to the myofibers and limiting exocrine contamination. Intramuscular islet graft function after transplantation was confirmed by documenting the acute insulin response to intravenous glucose in 5/11 pancreatectomized animals. Graft function after IMIT remained however significantly lower than the function measured in 12 out of 18 minipigs who received a similar islet volume in the liver through intraportal infusion. Collectively, these results demonstrated in a clinically relevant preclinical model, suggest IMIT as a promising alternative to intraportal infusion for the transplantation of cells in certain medical situations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available